We are live on ! Find out more
EP

Elkhorn Partners Portfolio holdings

AUM $117M
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+2.98%
1 Year Est. Return
+28.12%
3 Year Est. Return
+32.18%
5 Year Est. Return
+36.61%
10 Year Est. Return
+105.05%
AUM
$163M
AUM Growth
+$1.79M
Cap. Flow
-$2.89M
Cap. Flow %
-1.77%
Top 10 Hldgs %
96.89%
Holding
54
New
8
Increased
8
Reduced
17
Closed
11

Top Buys

Rank Stock Value
1
WBD icon
Warner Bros
WBD
+$454K
2
BABA icon
Alibaba
BABA
+$422K
3
GBT
Global Blood Therapeutics, Inc.
GBT
+$201K
4
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$142K
5
BA icon
Boeing
BA
+$109K

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.4M
2
CDZI icon
Cadiz
CDZI
+$1.31M
3
NUE icon
Nucor
NUE
+$430K
4
ERII icon
Energy Recovery
ERII
+$225K
5
CTO
CTO Realty Growth
CTO
+$218K

Sector Composition

Rank Sector Weight
1 Real Estate 52.5%
2 Financials 38.62%
3 Communication Services 3.41%
4 Industrials 2.06%
5 Technology 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VXX icon
26
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$132M
$112K 0.07%
+238
New +$142K
VTRS icon
27
Viatris
VTRS
$19.1B
$103K 0.06%
7,200
-1,100
-13% -$15.9K
RKT icon
28
Rocket Companies
RKT
$37.3B
$91K 0.06%
+4,700
New +$95.1K
NEPH icon
29
Nephros
NEPH
$46.6M
$86K 0.05%
8,500
-5,519
-39% -$46K
AMZN icon
30
Amazon
AMZN
$2.68T
$72K 0.04%
420
-300
-42% -$49.9K
AMGN icon
31
Amgen
AMGN
$203B
$49K 0.03%
200
+150
+300% +$36.9K
CRDF icon
32
Cardiff Oncology
CRDF
$104M
$40K 0.02%
6,000
+4,700
+362% +$39.9K
GILD icon
33
Gilead Sciences
GILD
$181B
$34K 0.02%
500
– –
JEF icon
34
Jefferies Financial Group
JEF
$11.3B
$32K 0.02%
994
-470
-32% -$14.3K
MP icon
35
MP Materials
MP
$8.76B
$26K 0.02%
+700
New +$21.8K
FLG
36
Flagstar Bank National Association
FLG
$5.33B
$22K 0.01%
+667
New +$23.9K
CRSP icon
37
CRISPR Therapeutics
CRSP
$5.01B
$20K 0.01%
+125
New +$15.2K
NUE icon
38
Nucor
NUE
$58.7B
$19K 0.01%
200
-4,600
-96% -$430K
MAX icon
39
MediaAlpha
MAX
$607M
$13K 0.01%
300
-900
-75% -$36K
NWLI
40
DELISTED
National Western Life Group, Inc. Class A
NWLI
$11K 0.01%
+50
New +$11.9K
AXTA icon
41
Axalta
AXTA
$7.12B
$8K ﹤0.01%
250
-750
-75% -$23.7K
FPH icon
42
Five Point Holdings
FPH
$363M
$5K ﹤0.01%
600
– –
BEP icon
43
Brookfield Renewable
BEP
$8.65B
– –
-400
Closed -$17K
CREX icon
44
Creative Realities
CREX
$36M
$0 ﹤0.01%
26
– –
CRM icon
45
Salesforce
CRM
$210B
– –
-170
Closed -$36K
GS icon
46
Goldman Sachs
GS
$284B
– –
-150
Closed -$49K
IFF icon
47
International Flavors & Fragrances
IFF
$21.5B
– –
-1,500
Closed -$209K
JPM icon
48
JPMorgan Chase
JPM
$937B
– –
-150
Closed -$23K
KMI icon
49
Kinder Morgan
KMI
$68.5B
– –
-300
Closed -$5K
KO icon
50
Coca-Cola
KO
$382B
– –
-600
Closed -$32K
1
2
3

Similar funds

KCA
Kilner Capital Advisors Gaithersburg, Maryland $117M AUM
WWA
Wisconsin Wealth Advisors Sun Prairie, Wisconsin $117M AUM 31.58% 1-Year Est. Return
VMMC
V.M. Manning & Co Greenville, South Carolina $117M AUM
AA
Advisory Advocates Grand Rapids, Michigan $117M AUM
TCRG
Twin Cities Retirement Group Plymouth, Minnesota $117M AUM
MAM
Markin Asset Management Rye, New York $117M AUM
SWA
Strategic Wealth Advisors Scottsdale, Arizona $117M AUM
MDA
Minot DeBlois Advisors Boston, Massachusetts $116M AUM 16.33% 1-Year Est. Return

Elkhorn Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Elkhorn Partners held 54 positions worth $163M, up 1.1% from $162M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Elkhorn Partners's Q2 2021 filing shows 8 new, 8 increased, 17 reduced and 11 closed positions. Its largest new stake was Warner Bros: 13,100 shares worth $402K. The largest sale was Berkshire Hathaway Class B, an estimated $1.4M.

By sector, the portfolio is most concentrated in Real Estate at 53% of assets, down from 54% a quarter earlier, followed by Financials and Communication Services.

  • Elkhorn Partners's largest Q2 2021 buy was Warner Bros: 13,100 shares worth $402K.
  • Elkhorn Partners added most to Alibaba in Q2 2021, an estimated $422K increase.
  • Elkhorn Partners's biggest Q2 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $1.4M.
  • Elkhorn Partners fully exited International Flavors & Fragrances in Q2 2021, selling an estimated $209K.
  • Elkhorn Partners's ten largest holdings make up 97% of its $163M portfolio in Q2 2021.
  • Elkhorn Partners opened 8 new positions and closed 11 in Q2 2021.
  • Elkhorn Partners's portfolio value rose 1.1% quarter-over-quarter to $163M.

Based on Elkhorn Partners's 13F filing for Q2 2021, filed 13 Aug 2021.